Logo

CORRECTED: BioTrove Purchases Patent Portfolio from Genencor

Oct 09, 2003

CORRECTION: A September 29, 2003 GenomeWeb News article stated that BioTrove had licensed from Genencor International a portfolio of patents and patents and patent filings related to nanofluidic through-hole array technology. In fact, BioTrove purchased the portfolio of patents from Genencor.  GenomeWeb regrets the error. The corrected story is below.

 

NEW YORK, Sept. 29 (GenomeWeb News) - BioTrove said it has purchased from Genencor International a portfolio of patents and patent filings related to nanofluidic through-hole array technology.

 

BioTrove said that the intellectual property would bolster its existing through-hole array technology patent portfolio with new method and device claims.  BioTrove said that the technology is used in its Living Chip platform for molecular, cell, and tissue screening and storage.

 

Specific terms of the licensing deal were not disclosed.

Breaking News
The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.